BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
LOADING
|||
Switch Symbol:
Debt to Equity Over Time
Above historical average, strong compound growth.
Left:
||||
Debt-to-equity ratio
Latest
-1.77
↑ 27% above average
Average (9y)
-2.43
Historical baseline
Range
High:2.21
Low:-14.51
CAGR
+44.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -1.77 | +2.4% |
| 2023 | -1.81 | +28.0% |
| 2022 | -2.52 | +54.6% |
| 2021 | -5.55 | +61.8% |
| 2020 | -14.51 | -755.7% |
| 2019 | 2.21 | +2720.2% |
| 2018 | -0.08 | +2.5% |
| 2017 | -0.09 | +8.7% |
| 2016 | -0.09 | -49.8% |
| 2015 | -0.06 | - |